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BACKGROUND: Hemoglobin S percentages are used in the management of patients who have sickle cell disease. However, hemoglobin S measurements often are not routinely or rapidly performed. Rapid and accurate methods to estimate hemoglobin S levels after simple transfusion may improve the care of patients with sickle cell disease.
STUDY DESIGN AND METHODS:
A comprehensive review of the electronic medical record identified 24 stable patients with sickle cell disease who received simple red blood cell transfusions and had hemoglobin S measurements before and after the transfusion that were less than 72 hours apart. Examination of these patients identified 62 separate transfusions that met our criteria. Three simple equations that utilized complete blood count values and readily available information from the medical record were used to predict the post-transfusion hemoglobin S level after transfusion ( 
RESULTS:
The predicted hemoglobin S values for all three equations showed a highly significant correlation with the measured post-hemoglobin S value. The coefficient of determination (R 2 ) for Equations 1, 2, and 3 was 0.95, 0.92, and 0.97, respectively. Predicting the post-transfusion hemoglobin S value using estimates of the patient's total hemoglobin and the transfused hemoglobin (Equation 3) was the most precise.
CONCLUSION: Reductions in hemoglobin S values in
patients with sickle cell disease who receive simple red blood cell transfusions can be reliably predicted using complete blood cell measurements and simple arithmetic equations.
S
ickle cell disease (SCD) is a common genetic hemoglobinopathy caused by a mutation in the bglobin chain at position 6 (glutamic acid to valine). This mutation results in SCD when found in the homozygous state or in combination with other mutations. 1 
MATERIALS AND METHODS

Study design
This project involved a retrospective query of our electronic medical record (EMR) to identify patients who had SCD and had received transfusions. The study was reviewed by the University Institutional Review Board (IRB) and was approved with a waiver of consent granted for the study by the IRB (no. 201410771). Utilizing the data-mining tool Starmaker, 10 the EMRs of patients at the University of Iowa Hospitals and Clinics were mined to identify all patients with non-zero HbS levels from 2010 through 2015. One hundred ninety-two patients were identified with non-zero HbS values during that period.
The HbS values (reported as the percentage HbS) available for each patient were then exported for further analysis. A drop in the HbS level between two measurements was used to identify patients who had received transfusion. HbS values can be influenced by patient erythropoiesis, bleeding, hemolysis, and treatment with drugs, such as hydroxyurea. Therefore, a window of 72 hours between HbS measurements was chosen to minimize these effects, and only transfusions in which HbS measurements were less than 72 hours apart were further analyzed. These restrictions resulted in the identification of 44 patients who had received at least one transfusion that met these criteria. A review of the EMRs of these patients (dating back to 2003) was performed to determine whether the patient had received a simple transfusion and was not bleeding or undergoing surgery or had evidence of clinically significant hemolysis. This eliminated 20 patients, most of whom had received either manual or automated exchange transfusions and thus were not eligible for study inclusion. This analysis left 24 patients who had received simple transfusions that met the above criteria and were analyzed for the current study. In total, 62 transfusions in these 24 patients met our criteria and were included in the analysis. All transfusions involved RBC units stored in ADSOL solution (adenine, dextrose, sorbitol, sodium chloride, and mannitol), and all patients with SCD received Sickledex-negative units (SICKLEDEX HGB S Solubility Test Kit; Streck). In addition, our policy is to utilize RBCs that are less than 7 days old in patients with SCD in nonemergent settings so that RBC survival is optimized.
The following parameters (in addition to the HbS [%] values) were recorded from the EMR for each transfusion that met the criteria described above: the time and values of Pre and Post Hb (g/dL) and hematocrit (Hct) (%) levels, and patient height (in cm) and weight (kg) nearest to the time of the transfusion. The volume (in dL) of transfused RBCs between the two HbS measurements was recorded with 3 dL (300 mL) per RBC unit estimated when the actual volume transfused was not documented in the EMR. The patient blood volume (in dL) at the time of the transfusion was estimated using the patient's sex, height, and weight. For pediatric patients (<40 kg), 80 mL/kg was utilized to estimate the blood volume. This value was selected for pediatric transfusions because this approach is commonly used in our hospital and is also very close to the mean value from a meta-analysis on blood volume for children in this age group.
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For non-obese patients (body mass index [BMI] <25 to >40 kg/m 2 ) a blood volume of 70 mL/kg was used for males, and 65 mL/kg was used for females. For patients who weighed greater than 40 kg and had a BMI greater than 25 kg/m 2 , the Nadler formula was used to estimate the blood volume. 12 None of the patients in our cohort who had a BMI greater than 25 kg/m 2 weighed less than 40 kg, but we would recommend using the Linderkamp nomogram to estimate blood volume in these individuals, 13 because the Nadler formula has not been validated for pediatric patients. 
Mathematical formulas for estimating the Post HbS level
We utilized Equations 1 and 2 (below) to predict the Post HbS level based on the Pre HbS (%) value and the Hb (g/ dL) or Hct (%) values obtained before (pre) and after (post) the transfusion(s). Because Hb changes proportionally with RBC transfusion, 14 these equations assume that the change in HbS is inversely proportional to the change in Hb or Hct. It should be noted that these equations do not factor in the changes in blood volume that are likely to occur in patients receiving transfusions and possibly other fluids. 
Statistical analysis
The measured and predicted HbS values for each of the transfusions were plotted and compared with the 45-degree identity line. Linear mixed modeling was performed with clustering on the patient level to calculate the best-fit line with 95% prediction intervals for new observations. Prediction intervals containing the identity line over the continuous range of predicted HbS would indicate that there is no significant difference between the measured and predicted HbS values. identified in an unbiased manner from a systematic search of the EMR. A comprehensive search of the EMRs of these patients identified 62 transfusion events that met the criteria outlined above (see Materials and Methods). A transfusion event is defined as all the RBC transfusions that occurred in between the two HbS measurements. Fifty-eight percent of the patients were females, 92% had HbSS disease, and 8% had HbSC disease. The means, medians, and ranges of the laboratory and patient variables for each transfusion event are shown in Table 1 . The majority of the transfusion events were in the pediatric population, but patients as old as 51 years were included in the analysis, and 17 transfusion events were analyzed in patients who weighed at least 50 kg.
RESULTS
Study design and transfusion variables
The number of transfusion events for each patient ranged from 1 to 16, and 18 of the patients had received only one or two transfusions that met our criteria for further analysis (Fig. 2A) . The transfusion volume generally involved one unit or less, and only two transfusion events involved three or more units (Fig. 2B) . Regarding the timing of the laboratory measurements, most HbS percentages were recorded within 24 hours of each other, and only six transfusion events involved HbS measurements more than 48 hours apart (Fig. 2C) .
Predicting the HbS percentage using Pre and Post CBC values
The predicted Post HbS value calculated using Equations 1 and 2 revealed a statistically significant correlation with the measured Post HbS value. The correlation was slightly better when patient Hb values were used (Eq. 1: coefficient of determination [R 2 ] 5 0.95) compared with Hct values (Eq. 2: R 2 5 0.91), but the results with either laboratory parameter were comparable (Fig. 3A,B) . Equations 1 and 2 slightly underestimated the drop in HbS compared with the measured Post HbS value by an average 3.34% using Hb and 3.73% using Hct. The precision of this equation did appear to be reduced as the interval between CBC measurements was increased. In seven transfusions with an interval of 48 to 72 hours between CBC measurements, Equation 1 overestimated the HbS value by an average of 7.41%, and the R 2 value was only 0.53 (data now shown).
The accuracy of predicting the Post HbS value was not (Fig. 3C) . Equation 3 was more precise, as the mean difference between predicted and measured HbS value was only 0.19% (range 27.7 to 8.5%).
To more clearly illustrate the precision and variation of each of these equations in predicting Post HbS values, the measured HbS was subtracted from the predicted HbS for all three equations, and the difference is illustrated in histogram format (Fig. 4 ). These data demonstrate that Equations 1 and 2 both tend to underestimate the drop in HbS level. Thus the predicted HbS percentage tends to be higher than the measured HbS percentage; therefore, the predicted minus measured values trend in the positive direction. For Equation 1, only three of 61 transfusions (4.9%) overestimated the drop in HbS value by more than 2%. Similarly, for Equation 2, only three of 42 transfusions (7.1%) overestimated the drop in HbS value by more than 2%. In contrast, the histogram of the data for Equation 3 is centered around zero; and, in 55 of 62 transfusions (88%), the predicted HbS value was within 5% of the measured value.
DISCUSSION
In this study, we performed a retrospective analysis of stable, nonbleeding patients with SCD who had received a simple transfusion in which both the Pre and Post HbS value had been measured. Three simple arithmetic equations were examined that utilized CBC parameters; the Pre HbS value; and the patient's sex, height, and weight to estimate the Post HbS level. Our data demonstrate that all three equations could reliably estimate the Post HbS level. Equations 1 and 2, which used pre-transfusion and post-transfusion CBC values to estimate the HbS value, tended to underestimate the reduction in HbS percentage. We speculate that this underestimation is due to the patient's expanded blood volume, which is likely to occur during transfusion. This volume expansion would result in an underestimate of the increase in a patient's Hb, because the equation assumes that the blood volume remains unchanged. Regardless of the reason, this approach provides a more conservative estimate for clinicians, and in only rare cases did this approach significantly overestimate the drop in HbS.
Equation 3 utilized estimates of the patient's total body Hb and the total transfused Hb to predict the drop in HbS percentage after transfusion. This method does not require any post-transfusion testing and thus can be used to estimate the drop in HbS levels before the transfusion even occurs. We suspect that much of the variation observed using this equation may come from differences in Hb levels among different units and possibly imprecise estimates of the transfused blood volume. The measurement of the Hb in each individual unit and careful assessment of the volume of each unit would likely improve the precision of this equation, but those values were not available for the current study. Other variation with this method could come from the estimates of blood volume, because significant variation occurs in patient blood volumes. 12, 13 However, Equation 3 did provide the most precise estimate of the drop in HbS levels, because the mean difference in predicted and measured HbS values was near zero. We envision several scenarios in which using these equations might prove beneficial. Patients with SCD in crisis often receive simple transfusion before RBC exchanges can be arranged or are necessary. In this setting, these equations can be used to estimate the HbS level before the RBC exchange. For these procedures, the Pre HbS level is important for determining the FCR, and the FCR is required to determine the number of RBC units needed for the procedure. Because HbS levels are often not rapidly available, utilizing the equations described here might assist with the clinician's estimate of this value. Another scenario would be patients with SCD who have very low Hb levels for which the clinical team is deciding between a simple transfusion and an exchange transfusion. For example, if a patient's Hct is 14% and the HbS value is 60%, then Equation 2 could be utilized to conservatively predict that transfusing up to an Hct of 30% would have a high probability of reducing the HbS value to 30%. In this scenario, with Equation 2, we could predict the HbS value as follows: 60% 3 (14%/30%) 5 28%. Because simple transfusions generally do not require a central line, whereas exchange transfusions do, the costs and potential complications of placing a central line could be avoided in a patient like this. Finally, if there is an end HbS target in mind for a patient with SCD who is about to receive a transfusion, then Equation 3 can be used to determine how much blood to transfuse in order to achieve a specific target HbS value. For example, if a pediatric patient weighs 25 kg (for an estimated blood volume of 25 3 80 5 2000 mL), has an Hb value of 5.0 g/ dL, and an HbS of 50%, then the amount of transfused blood required to drop the HbS value to 30% could be calculated. In this scenario, the pre-transfusion total body Hb would be estimated as 100 g (20 dL 3 5 g/dL). Transfusing 325 mL (3.25 dL 3 20 g/dL 5 65 g estimated 
